December 19, 2014 5:26 AM ET

Biotechnology

Company Overview of Epoch Biosciences, Inc.

Executive Profile

Merl Hoekstra

Group Vice President of Business Development, ELITech Group S.A.S.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 3 different industries.

See Board Relationships
54--

Background

Dr. Merl Hoekstra serves as Group Vice President at Business Development at ELITech Group S.A.S. Dr. Hoekstra served as a Vice President of Corporate Development at Epoch Biosciences, Inc. since March 2001. Dr. Hoekstra served as Chief Science Officer and General Manager of Qbiogene, Inc. From 1998 to 2000, Dr. Hoekstra served as Vice President of Target Discovery at Signal Pharmaceuticals, Inc. From 1992 to 1998, Dr. Hoekstra was Senior Director, Science, at Icos Corporation, ...

Corporate Headquarters

21720 23rd Drive SE
Bothell, Washington 98021

United States

Phone: 425-482-5555
Fax: 425-482-5550

Board Members Memberships

Director

Education

BS
University Of British Columbia
PhD
Stritch School Of Medicine, Loyola University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Epoch Biosciences, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.